Precision injection showdown: which spot stops frozen shoulder pain best?

NCT ID NCT07710651

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This trial tests two ways to deliver a steroid injection for adhesive capsulitis, or frozen shoulder — a condition that causes pain and stiffness. One method injects into the shoulder joint, the other into the tissue around it, both guided by ultrasound. Researchers want to see which approach better reduces pain and improves movement in daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
betamethasone combined with lidocaine, given as an ultrasound-guided injection
What this could lead to
If one technique proves superior, it could become the preferred standard for treating frozen shoulder, offering faster pain relief and better shoulder function.
What could go wrong
This is a small, early-stage trial with only 34 participants, so results may not apply to everyone. Steroid injections carry risks like infection or tendon damage, and the benefit may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Aug 2023

Finished

Mar 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: -Diagnosis of unilateral adhesive capsulitis, characterized by shoulder pain and restriction of both active and passive range of motion. Exclusion Criteria: * Secondary glenohumeral joint motion limitation due to inflammatory, degenerative, metabolic, or infectious arthritis. * History of cerebrovascular accident (stroke). * History of fracture involving the affected shoulder. * Presence of any neurological deficit affecting the upper extremity. * Previous surgery involving the affected shoulder. * History of shoulder trauma. * Pregnancy or breastfeeding. * Known hypersensitivity or allergic reaction to local anesthetics or corticosteroids used in the study. * Current use of anticoagulant therapy. * Active inflammatory or infectious disease. * Active psychiatric disorder. * Uncontrolled hypertension. * Uncontrolled diabetes mellitus. * Uncompensated chronic heart, liver, or renal failure. * Presence of vascular or malignant disease affecting the shoulder region.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adhesive capsulitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istanbul University- Cerrahpasa

    Istanbul, Fatih, 34093, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.